top of page
Blog: Blog2
Search

Vagal Nerve Stimulation Market Overview with Detailed Analysis, Competitive landscape, Forecast to 2

Writer: nita bombarenita bombare

overview:

Vagal Nerve Stimulation Market Research Report- Global Forecast till 2023

Research Future (MRFR) in their recent article on the vagal nerve stimulation market declared that the vagal nerve stimulation market is expected to rise by 8.68% CAGR during the forecast period (2017-2023). It would attain significant market valuation by the end of 2023. Vagal nerve stimulation is the process to get the vagal nerve stimulated with electrical impulses.

The vagal nerve, also known as the vagus nerve, runs from the brainstem to abdomen via neck and chest. The procedure involves the implantation of a stimulator under the skin on the chest where a wire connects it with the left vagal nerve. Upon activation, the machine sends a signal to the brainstem which then triggers certain parts of the body. Vagal nerve stimulation works great with issues like pain, depression, and epilepsy. MRFR, while discussing the vagal nerve stimulation market, included segmental analysis and factors that can be decisive in the coming years.

As one of the major market factors, non-invasive techniques can take the market ahead in the coming years. Other than this, biotechnology and pharmaceutical companies are investing in the market substantially to promote growth and develop new products. Increased application of the sector in curing various diseases and rising supports in reimbursing the cost is bound to take the market forward.

Despite such advantages, the high cost of the treatment can prohibit the market from having the predicted CAGR during the forecast period. But innovations can always steer the market clear out of any long-time sluggishness.

Competitive Analysis:

Notable players influencing the vagal nerve stimulation market, as per the reports of MRFR, are EnteroMedics Inc. (US), Cyberonics, Inc. (US), LivaNova PLC (UK), Boston Scientific Corporation (US), ElectroCore Medical LLC (US), ImThera Medical (US), NeuroMetrix, Inc. (US), and Inspire Medical Systems, Inc. (US).

In 2018, electroCore of New Jersey launched a non-invasive vagal nerve stimulator that can be used in treating a cluster headache. The latest version is called Sapphire. When placed on the vagus nerve, it sends electric current towards the brain to disrupt the causes of pain.

Vagal Nerve Stimulation (VNS) Market Information: By Product (Implantable VNS Devices and External VNS Devices), By Application (Depression, Epilepsy, Migraine, And Others), By End Users (Hospitals, Ambulatory Surgical Centers, And Others) - Global Forecast Till 2023 : https://www.marketresearchfuture.com/reports/vagal-nerve-stimulation-market-4479

 
 
 

Recent Posts

See All

Comentários


bottom of page